News
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
1h
inews.co.uk on MSN1.5m Britons a month pay for weight-loss jabs - and pharmacies 'ready' to step upHigh-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
5d
inews.co.uk on MSNThe unexpected benefits of weight loss jabs - and the downsidesDoctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Enhanced weight loss effects of NT-0796 and semaglutide in combination ...
Amazon talks up AI potential on earnings call, points to limited tariff impact. American Airlines commits to $4 billion ...
Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...
Companies are developing myostatin inhibitors for GLP-1RA- related muscle loss, but some experts doubt their necessity.
StockStory.org on MSN2d
Why Is WeightWatchers (WW) Stock Soaring TodayShares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 132% in the afternoon session after the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results